Technology · Biotechnology R&D expenditure
US spending on biotechnology research and development in 2026 is 30 B $, ranking 1st. However, the real picture is different: American corporations like Amgen and Gilead Sciences invest tens of billions in new drugs and gene therapy. The zero figure likely reflects methodology—major investments flow through the private sector in Boston and San Francisco, not government programs.
Data for 2026 · unit: $
Position
#1 / 197
USA world ranking
Country position on the scale from last to first place for this indicator.
US
#1
#197#1
Trend
Change over time
Change in indicator over the available period.
15 B
1990
30 B
2000
20 B
2010
30 B
2020
28 B
2025
30 B
2026
Values — $
Comparison
Top countries by Biotechnology R&D expenditure
Where USA stands in the world ranking.
1
CNChina
30 B
1
USUSA
30 B
3
JPJapan
25 B
4
MXMexico
1 B
4
BRBrazil
1 B
6
CACanada
800 M
6
DEGermany
800 M
8
ESSpain
650 M
Full world rankingarrow_forward
People also search for
Other pages of the reference by this indicator.
Frequently asked questions
Biotechnology R&D expenditure in USA — how much?
Based on 2026 data — 30 B $. This is rank #1 out of 197 countries.
What is USA's rank by Biotechnology R&D expenditure?
USA ranks #1 out of 197 countries in the world ranking by «Biotechnology R&D expenditure».
How has Biotechnology R&D expenditure changed in USA?
Over the available period the indicator changed from 15 B to 30 B $.